Curatis Holding AG (XSWX:CURN) Net Margin %: -4.52% (As of Dec. 2025)


XSWX:CURN Curatis Holding AG XSWX:CURN
33 GF Score
Price CHF23.60
! 7 Warning Signs
View Full Analysis

What is Curatis Holding AG Net Margin %?

Curatis Holding AG XSWX:CURN +3.51% 33 Net Margin % is -4.52% as of Dec. 2025. GuruFocus rates XSWX:CURN with a GF Score™ of 33/100. The stock has 7 warning signs investors should review. Among 955 Drug Manufacturers companies, Curatis Holding AG ranks worse than 77.7% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Curatis Holding AG's Net Income for the six months ended in Dec. 2025 was CHF-0.25 Mil. Curatis Holding AG's Revenue for the six months ended in Dec. 2025 was CHF5.56 Mil. Therefore, Curatis Holding AG's net margin for the quarter that ended in Dec. 2025 was -4.52%.

The historical rank and industry rank for Curatis Holding AG's Net Margin % or its related term are showing as below:

XSWX:CURN' s Net Margin % Range Over the Past 10 Years
Min: -63.01   Med: -38.06   Max: -13.11
Current: -13.11

XSWX:CURN's Net Margin % is ranked worse than
77.7% of 955 companies
in the Drug Manufacturers industry
Industry Median: 5.69 vs XSWX:CURN: -13.11

Curatis Holding AG  (XSWX:CURN) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Curatis Holding AG Net Margin % Related Terms

Curatis Holding AG Net Margin % Historical Data

* Premium members only.

The historical data trend for Curatis Holding AG's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curatis Holding AG Net Margin % Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
0.00 0.00 0.00 -63.01 -13.11

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -195.50 -9.68 -22.22 -4.52

XSWX:CURN vs ZTS, UTHR, VTRS: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curatis Holding AG Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's Net Margin % distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's Net Margin % falls into.


XSWX:CURN
33GF Score
Curatis Holding AG XSWX:CURN
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curatis Holding AG Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Curatis Holding AG's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.416/10.8
=-13.11 %

Curatis Holding AG's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.251/5.557
=-4.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -4.52% mean?
Curatis Holding AG (XSWX:CURN) has a Net Margin % of -4.52% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Curatis Holding AG and its competitors. According to the industry distribution chart, Curatis Holding AG ranks #742 out of 955 companies in the Drug Manufacturers industry, placing it in the top 77.7%.
Is Curatis Holding AG's Net Margin % too high?
Curatis Holding AG's current Net Margin % is -4.52%. Based on the distribution chart, Curatis Holding AG ranks #742 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Curatis Holding AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Curatis Holding AG's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Curatis Holding AG ranks #742 out of 955 companies for Net Margin %. This places Curatis Holding AG in the lower half of its industry. The industry median Net Margin % is 5.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.69, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Curatis Holding AG and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curatis Holding AG's current Net Margin % is -4.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curatis Holding AG stock overvalued right now?
Curatis Holding AG (XSWX:CURN) has a current Net Margin % of -4.52%. The current Net Margin % is -4.52%. Curatis Holding AG's overall GF Score™ is 33/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Curatis Holding AG (XSWX:CURN), the current Net Margin % is -4.52% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curatis Holding AG Business Description

Other Exchanges CURNz:UK0QNS:UK26U:Germany
Address Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical Company with two-pillar. On one hand, the Company trades and distributes specialty medicines in the rare disease and specialty medicines space i.e. acquires, licenses, distributes and promotes pharmaceutical products for the treatment and/or prevention of rare and specialty diseases in Switzerland. On the other hand, it is a drug development Company with a pipeline of product candidates, also predominantly in the orphan drug space.
33GF Score

Get the complete analysis for XSWX:CURN

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF23.60
Price